Your browser doesn't support javascript.
loading
Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial.
Schneeweiss, Andreas; Möbus, Volker; Tesch, Hans; Hanusch, Claus; Denkert, Carsten; Lübbe, Kristina; Huober, Jens; Klare, Peter; Kümmel, Sherko; Untch, Michael; Kast, Karin; Jackisch, Christian; Thomalla, Jörg; Ingold-Heppner, Barbara; Blohmer, Jens-Uwe; Rezai, Mahdi; Frank, Matthias; Engels, Knut; Rhiem, Kerstin; Fasching, Peter Andreas; Nekljudova, Valentina; von Minckwitz, Gunter; Loibl, Sibylle.
Afiliação
  • Schneeweiss A; National Center for Tumor Diseases (NCT) Heidelberg, Germany.
  • Möbus V; Department of Gynaecology and Obstetrics, Clinic Frankfurt-Hoechst, Germany.
  • Tesch H; Praxis Bethanien, Frankfurt, Germany.
  • Hanusch C; Clinic of Red Cross, Munich, Germany.
  • Denkert C; Charité University Hospital Berlin, Germany.
  • Lübbe K; Henriettenstiftung Hannover, Germany.
  • Huober J; University Hospital Ulm, Germany.
  • Klare P; Praxisklinik Krebsheilkunde für Frauen Berlin, Germany.
  • Kümmel S; Breast Center, Clinic Essen-Mitte, Germany.
  • Untch M; HELIOS Clinic Berlin-Buch, Germany.
  • Kast K; University Hospital Dresden, Germany.
  • Jackisch C; Sana-Clinic Offenbach, Germany.
  • Thomalla J; Clinic for Haematology and Oncology Koblenz, Germany.
  • Ingold-Heppner B; Charité University Hospital Berlin, Germany.
  • Blohmer JU; Charité University Hospital Berlin, Germany.
  • Rezai M; Medical Center, Luisenkrankenhaus Düsseldorf, Germany.
  • Frank M; Ortenau Clinics, Germany.
  • Engels K; Zentrum für Pathologie, Zytologie und Molekularpathologie Neuss, Germany.
  • Rhiem K; ClinicCenter for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Germany.
  • Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Germany.
  • Nekljudova V; German Breast Group, Neu-Isenburg, Germany.
  • von Minckwitz G; German Breast Group, Neu-Isenburg, Germany.
  • Loibl S; Praxis Bethanien, Frankfurt, Germany; German Breast Group, Neu-Isenburg, Germany. Electronic address: sibylle.loibl@gbg.de.
Eur J Cancer ; 106: 181-192, 2019 01.
Article em En | MEDLINE | ID: mdl-30528802
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epirubicina / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Carboplatina / Paclitaxel / Terapia Neoadjuvante / Ciclofosfamida / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epirubicina / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Carboplatina / Paclitaxel / Terapia Neoadjuvante / Ciclofosfamida / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido